ConvaTec Shares Drop Again as Wound-Care Warning Puts 2026 Growth Plan in Focus
Convatec shares fell 1.69% to £2.21 in London Friday, closing nearly 30% below their 52-week high as investors reacted to weakness in the wound-care market. The drop followed Coloplast’s cut to its 2025/26 outlook and a DKK 3 billion impairment on its Kerecis business. Convatec expects InnovaMatrix revenue to fall to $20 million in 2026 due to U.S. Medicare changes.